company background image
ARIX

Arix Bioscience LSE:ARIX Stock Report

Last Price

UK£1.05

Market Cap

UK£129.7m

7D

-2.6%

1Y

-18.4%

Updated

04 Dec, 2022

Data

Company Financials
ARIX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ARIX Stock Overview

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity.

Arix Bioscience plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Arix Bioscience
Historical stock prices
Current Share PriceUK£1.05
52 Week HighUK£1.36
52 Week LowUK£1.00
Beta1.24
1 Month Change-4.57%
3 Month Change-11.81%
1 Year Change-18.36%
3 Year Change0%
5 Year Change-44.86%
Change since IPO-50.00%

Recent News & Updates

Recent updates

Arix Bioscience plc's (LON:ARIX) Business And Shares Still Trailing The Market

Jan 13
Arix Bioscience plc's (LON:ARIX) Business And Shares Still Trailing The Market

Shareholder Returns

ARIXGB Capital MarketsGB Market
7D-2.6%0.3%0.8%
1Y-18.4%-8.2%-6.0%

Return vs Industry: ARIX underperformed the UK Capital Markets industry which returned -8.2% over the past year.

Return vs Market: ARIX underperformed the UK Market which returned -5.9% over the past year.

Price Volatility

Is ARIX's price volatile compared to industry and market?
ARIX volatility
ARIX Average Weekly Movement2.7%
Capital Markets Industry Average Movement4.8%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.9%

Stable Share Price: ARIX is less volatile than 75% of UK stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: ARIX's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20157Rob Lynehttps://arixbioscience.com

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally.

Arix Bioscience plc Fundamentals Summary

How do Arix Bioscience's earnings and revenue compare to its market cap?
ARIX fundamental statistics
Market CapUK£129.68m
Earnings (TTM)-UK£52.68m
Revenue (TTM)n/a

-2.6x

P/S Ratio

-2.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ARIX income statement (TTM)
Revenue-UK£50.33m
Cost of RevenueUK£0
Gross Profit-UK£50.33m
Other ExpensesUK£2.35m
Earnings-UK£52.68m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.42
Gross Margin100.00%
Net Profit Margin104.66%
Debt/Equity Ratio0%

How did ARIX perform over the long term?

See historical performance and comparison